A new chapter in immune checkpoint inhibitor therapy: starting with advanced lung squamous cell carcinoma

por Fei, Kailun, Xu, Jiachen, Wang, Zhijie
Publicado 2020

Metagenome association study of the gut microbiome revealed biomarkers linked to chemotherapy outcomes in locally advanced and advanced lung cancer

por Zhao, Zhe, Fei, Kailun, Bai, Hua, Wang, Zhijie, Duan, Jianchun, Wang, Jie
Publicado 2020

TP53 mutations in circulating tumor DNA in advanced epidermal growth factor receptor-mutant lung adenocarcinoma patients treated with gefitinib

por Yu, Ruofei, Bai, Hua, Li, Tangai, Gao, Bingyu, Han, Jiefei, Chang, Geyun, Zhang, Pei, Fei, Kailun, He, Xiran, Wang, Jie
Publicado 2021

Multi-omics indicators of long-term survival benefits after immune checkpoint inhibitor therapy

por Zhao, Jie, Dong, Yiting, Bai, Hua, Bai, Fan, Yan, Xiaoyan, Duan, Jianchun, Wan, Rui, Xu, Jiachen, Fei, Kailun, Wang, Jie, Wang, Zhijie
Publicado 2023

Construction and Comprehensive Analyses of a METTL5-Associated Prognostic Signature With Immune Implication in Lung Adenocarcinomas

por Sun, Sijin, Fei, Kailun, Zhang, Guochao, Wang, Juhong, Yang, Yannan, Guo, Wei, Yang, Zhenlin, Wang, Jie, Xue, Qi, Gao, Yibo, He, Jie
Publicado 2021

Abnormal activation of NF‐κB and MAPK signaling pathways affect osimertinib resistance and influence the recruitment of myeloid‐derived suppressor cells to shape the immunosuppress...

por Wang, Chao, Fei, Kailun, Liu, Lihui, Duan, Jianchun, Wang, Zhijie, Li, Sini, Xu, Jiachen, Zhang, Xue, Tian, Yanhua, Qu, Yan, Bai, Hua, Wang, Jie
Publicado 2023

Development and validation of a nomogram based on preoperative variables for predicting recurrence‐free survival in stage IA lung adenocarcinoma

por Xu, Jiaxi, Zeng, Hui, Zhang, Guochao, Li, Renda, Yuan, Zhenlong, Ren, Jingyu, Huang, Yufei, Ren, Fangzhou, Zhang, Hao, Fei, Kailun, Feng, Feiyue, Tan, Fengwei
Publicado 2023

Effect of dexmedetomidine on postoperative systemic inflammation and recovery in patients undergoing digest tract cancer surgery: A meta-analysis of randomized controlled trials

por Xu, Wenjie, Zheng, Yuxiang, Suo, Zizheng, Fei, Kailun, Wang, Yalong, Liu, Chao, Li, Shuai, Zhang, Mingzhu, Zhang, Yefan, Zheng, Zhaoxu, Ni, Cheng, Zheng, Hui
Publicado 2022

Effectiveness of neoadjuvant immunochemotherapy compared to neoadjuvant chemotherapy in non-small cell lung cancer patients: Real-world data of a retrospective, dual-center study

por Fei, Kailun, Guo, Gang, Wang, Jie, Wang, Zhijie, Wang, Yan, Hao, Xuezhi, Zhong, Jia, Guo, Qinxiang, Guo, Wei, Su, Wenzhong, Zan, Likun, Xu, Jiaxi, Tan, Fengwei, Zhuang, Xiaofei, Duan, Jianchun
Publicado 2023

Upfront dose-reduced chemotherapy synergizes with immunotherapy to optimize chemoimmunotherapy in squamous cell lung carcinoma

por He, Xiran, Du, Yang, Wang, Zhijie, Wang, Xin, Duan, Jianchun, Wan, Rui, Xu, Jiachen, Zhang, Pei, Wang, Di, Tian, Yanhua, Han, Jiefei, Fei, Kailun, Bai, Hua, Tian, Jie, Wang, Jie
Publicado 2020

Optimized dose selective HDAC inhibitor tucidinostat overcomes anti-PD-L1 antibody resistance in experimental solid tumors

por Zhang, Pei, Du, Yang, Bai, Hua, Wang, Zhijie, Duan, Jianchun, Wang, Xin, Zhong, Jia, Wan, Rui, Xu, Jiachen, He, Xiran, Wang, Di, Fei, Kailun, Yu, Ruofei, Tian, Jie, Wang, Jie
Publicado 2022

A prognostic and immunotherapeutic predictive model based on the cell-originated characterization of tumor microenvironment in lung adenocarcinoma

por Xu, Jiachen, Yang, Zhenlin, Xie, Wenchuan, Wan, Rui, Li, Chengcheng, Fei, Kailun, Sun, Boyang, Yang, Xu, Chen, Ping, Meng, Fanqi, Wang, Guoqiang, Zhao, Jing, Han, Yusheng, Cai, Shangli, Wang, Jie, Wang, Zhijie
Publicado 2023

A novel tumor mutational burden estimation model as a predictive and prognostic biomarker in NSCLC patients

por Tian, Yanhua, Xu, Jiachen, Chu, Qian, Duan, Jianchun, Zhang, Jianjun, Bai, Hua, Yang, Zhenlin, Fang, Wenfeng, Cai, Liangliang, Wan, Rui, Fei, Kailun, He, Jie, Gao, Shugeng, Zhang, Li, Wang, Zhijie, Wang, Jie
Publicado 2020

Safety, Antitumor Activity, and Pharmacokinetics of Toripalimab, a Programmed Cell Death 1 Inhibitor, in Patients With Advanced Non–Small Cell Lung Cancer: A Phase 1 Trial

por Wang, Zhijie, Ying, Jianming, Xu, Jiachen, Yuan, Pei, Duan, Jianchun, Bai, Hua, Guo, Changyuan, Li, Lin, Yang, Zhenlin, Wan, Rui, Fei, Kailun, Zhao, Zhe, Du, Xinyang, Zhao, Junhui, Lv, Ning, Wang, Jie
Publicado 2020

EPHA mutation as a predictor of immunotherapeutic efficacy in lung adenocarcinoma

por Bai, Hua, Duan, Jianchun, Li, Chengcheng, Xie, Wenzhuan, Fang, Wenfeng, Xu, Yu, Wang, Guoqiang, Wan, Rui, Sun, Jing, Xu, Jiachen, Wang, Xin, Fei, Kailun, Zhao, Zhengyi, Cai, Shangli, Zhang, Li, Wang, Jie, Wang, Zhijie
Publicado 2020

Ablation of ERO1A induces lethal endoplasmic reticulum stress responses and immunogenic cell death to activate anti-tumor immunity

por Liu, Lihui, Li, Sini, Qu, Yan, Bai, Hua, Pan, Xiangyu, Wang, Jian, Wang, Zhijie, Duan, Jianchun, Zhong, Jia, Wan, Rui, Fei, Kailun, Xu, Jiachen, Yuan, Li, Wang, Chao, Xue, Pei, Zhang, Xue, Ma, Zixiao, Wang, Jie
Publicado 2023

Influence of adjuvant chemotherapy on survival for patients with stage IB and IIA non‐small cell lung cancer

por Zhang, Pei, Duan, Jianchun, Bai, Hua, Wang, Zhijie, Gao, Shugeng, Tan, Fengwei, Gao, Yushun, Wang, Xin, Wan, Rui, Xu, Jiachen, He, Xiran, Feng, Xiaoshuang, Yu, Ruofei, Sun, Jing, Zhao, Zhe, Fei, Kailun, Li, Ni, He, Jie, Wang, Jie
Publicado 2020

Weighting tumor-specific TCR repertoires as a classifier to stratify the immunotherapy delivery in non–small cell lung cancers

por Han, Jiefei, Yu, Ruofei, Duan, Jianchun, Li, Jin, Zhao, Wei, Feng, Guoshuang, Bai, Hua, Wang, Yuqi, Zhang, Xue, Wan, Rui, Xu, Jiachen, Wang, Xin, Guan, Yanfang, Xia, Xuefeng, Yao, Zhuoran, Fei, Kailun, Carbone, David P., Wang, Zhijie, Wang, Jie
Publicado 2021

Genomic and epigenomic profiles distinguish pulmonary enteric adenocarcinoma from lung metastatic colorectal cancer

por Zuo, Ying, Zhong, Jia, Bai, Hua, Xu, Bin, Wang, Zhijie, Li, Weihua, Chen, Yedan, Jin, Shi, Wang, Shuhang, Wang, Xin, Wan, Rui, Xu, Jiachen, Fei, Kailun, Han, Jiefei, Yang, Zhenlin, Bao, Hua, Shao, Yang, Ying, Jianming, Song, Qibin, Duan, Jianchun, Wang, Jie
Publicado 2022

Single-cell transcriptomic profiling reveals the tumor heterogeneity of small-cell lung cancer

por Tian, Yanhua, Li, Qingqing, Yang, Zhenlin, Zhang, Shu, Xu, Jiachen, Wang, Zhijie, Bai, Hua, Duan, Jianchun, Zheng, Bo, Li, Wen, Cui, Yueli, Wang, Xin, Wan, Rui, Fei, Kailun, Zhong, Jia, Gao, Shugeng, He, Jie, Gay, Carl M., Zhang, Jianjun, Wang, Jie, Tang, Fuchou
Publicado 2022